Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MicroRNA-132 provides neuroprotection for tauopathies via multiple signaling pathways
Rachid El Fatimy, Shaomin Li, Zhicheng Chen, et al.
Acta Neuropathologica (2018) Vol. 136, Iss. 4, pp. 537-555
Open Access | Times Cited: 135

Showing 1-25 of 135 citing articles:

Exosome Processing and Characterization Approaches for Research and Technology Development
James J. Lai, Zoe L. Chau, Sheng‐You Chen, et al.
Advanced Science (2022) Vol. 9, Iss. 15
Open Access | Times Cited: 302
MicroRNAs in Alzheimer’s Disease
Mengli Wang, Lixia Qin, Beisha Tang
Frontiers in Genetics (2019) Vol. 10
Open Access | Times Cited: 285
Interplay between MicroRNAs and Oxidative Stress in Neurodegenerative Diseases
Julia Konovalova, Dmytro Gerasymchuk, Ilmari Parkkinen, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 23, pp. 6055-6055
Open Access | Times Cited: 175
miR-212 and miR-132 Are Downregulated in Neurally Derived Plasma Exosomes of Alzheimer’s Patients
Jean‐Sébastien Diana, David Mengel, Maja Mustapić, et al.
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 169
Restoring miR-132 expression rescues adult hippocampal neurogenesis and memory deficits in Alzheimer’s disease
Hannah Walgrave, Sriram Balusu, Sarah Snoeck, et al.
Cell stem cell (2021) Vol. 28, Iss. 10, pp. 1805-1821.e8
Open Access | Times Cited: 125
MicroRNAs: pioneering regulators in Alzheimer’s disease pathogenesis, diagnosis, and therapy
Yao-Bo Li, Qiang Fu, Mei Guo, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 17
Evolving therapeutic interventions for the management and treatment of Alzheimer’s disease
Faizan Ahmad, Anik Karan, Rashi Sharma, et al.
Ageing Research Reviews (2024) Vol. 95, pp. 102229-102229
Closed Access | Times Cited: 16
Increased miR‐34c mediates synaptic deficits by targeting synaptotagmin 1 through ROS‐JNK‐p53 pathway in Alzheimer’s Disease
Zhongli Shi, Kaixia Zhang, Huimin Zhou, et al.
Aging Cell (2020) Vol. 19, Iss. 3
Open Access | Times Cited: 99
A combined miRNA–piRNA signature to detect Alzheimer’s disease
Gaurav Jain, Anne Stuendl, Pooja Rao, et al.
Translational Psychiatry (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 96
MicroRNA-132 attenuates cerebral injury by protecting blood-brain-barrier in MCAO mice
Xiaokun Zuo, Jianfei Lu, Manaenko Anatol, et al.
Experimental Neurology (2019) Vol. 316, pp. 12-19
Closed Access | Times Cited: 95
Competing Endogenous RNA Networks as Biomarkers in Neurodegenerative Diseases
Leticia Moreno‐García, Tresa López‐Royo, Ana Cristina Calvo, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 24, pp. 9582-9582
Open Access | Times Cited: 94
The promise of microRNA-based therapies in Alzheimer’s disease: challenges and perspectives
Hannah Walgrave, Lujia Zhou, Bart De Strooper, et al.
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 89
Addressing heterogeneity in amyotrophic lateral sclerosis CLINICAL TRIALS
Namita Goyal, James Berry, Anthony J. Windebank, et al.
Muscle & Nerve (2020) Vol. 62, Iss. 2, pp. 156-166
Open Access | Times Cited: 79
The neurobiology of non-coding RNAs and Alzheimer’s disease pathogenesis: Pathways, mechanisms and translational opportunities
Elisabetta Lauretti, Konrad Dabrowski, Domenico Praticò
Ageing Research Reviews (2021) Vol. 71, pp. 101425-101425
Open Access | Times Cited: 73
The Potential Neuroprotective Role of Free and Encapsulated Quercetin Mediated by miRNA against Neurological Diseases
Tarek Benameur, Raffaella Soleti, Chiara Porro
Nutrients (2021) Vol. 13, Iss. 4, pp. 1318-1318
Open Access | Times Cited: 59
The Eminent Role of microRNAs in the Pathogenesis of Alzheimer's Disease
Mohammad Samadian, Mahdi Gholipour, Mohammadreza Hajiesmaeili, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 58
The role of microRNAs in neurobiology and pathophysiology of the hippocampus
Seyed Khalil Rashidi, Ata Kalirad, Shahram Rafie, et al.
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 24
Small molecule regulators of microRNAs identified by high-throughput screen coupled with high-throughput sequencing
Lien D. Nguyen, Zhiyun Wei, M. Catarina Silva, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 23
GSK3: A potential target and pending issues for treatment of Alzheimer's disease
Jiahui Zhao, Mengying Wei, Min‐Song Guo, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 7
Open Access | Times Cited: 13
Non-Coding RNAs in Neurological and Neuropsychiatric Disorders: Unraveling the Hidden Players in Disease Pathogenesis
Mirolyuba Ilieva
Cells (2024) Vol. 13, Iss. 12, pp. 1063-1063
Open Access | Times Cited: 10
Exosomes and non-coding RNAs: bridging the gap in Alzheimer’s pathogenesis and therapeutics
Chunhui Guo, You Yanqiu, Jibing Chen, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 1
Open Access | Times Cited: 1
Long non‐coding RNAs as key regulators of neurodegenerative protein aggregation
Qi Xu, Dan Liu, Ling‐Qiang Zhu, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 2
Open Access | Times Cited: 1
Nose-to-brain delivery of enveloped RNA - cell permeating peptide nanocomplexes for the treatment of neurodegenerative diseases
Eleni Samaridou, Hannah Walgrave, Evgenia Salta, et al.
Biomaterials (2019) Vol. 230, pp. 119657-119657
Open Access | Times Cited: 72
Silencing miR‐21 induces polarization of astrocytes to the A2 phenotype and improves the formation of synapses by targeting glypican 6 via the signal transducer and activator of transcription‐3 pathway after acute ischemic spinal cord injury
Yanlin Su, Zhe Chen, Hongxia Du, et al.
The FASEB Journal (2019) Vol. 33, Iss. 10, pp. 10859-10871
Closed Access | Times Cited: 71
Transcriptomics in Alzheimer’s Disease: Aspects and Challenges
Eva Bagyinszky, Vo Van Giau, SeongSoo A. An
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 10, pp. 3517-3517
Open Access | Times Cited: 59
Page 1 - Next Page

Scroll to top